Janet Kunsman

Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström Macroglobulinemia

Irene M. Ghobrial, Fangxin Hong, Ashraf Badros et al. · Journal of Clinical Oncology · 2010 · 165 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia

Irene M. Ghobrial, Wanling Xie, Ashraf Badros et al. · American Journal of Hematology · 2010 · 148 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Weekly bortezomib in combination with temsirolimus in relapsed or relapsed and refractory multiple myeloma: a multicentre, phase 1/2, open-label, dose-escalation study

Irene M. Ghobrial, Edie Weller, Ravi Vij et al. · The Lancet Oncology · 2011 · 97 citations

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of direct and indirect methods of measuring arterial blood pressure, part II.

JMR Bruner, Laurence J. Krenis, Janet Kunsman et al. · PubMed · 1981 · 54 citations

Engineering, Physiology, Surgery +11

A Prospective Multicenter Study Of The Bruton’s Tyrosine Kinase Inhibitor Ibrutinib In Patients With Relapsed Or Refractory Waldenstrom’s Macroglobulinemia

Steven P. Treon, Christina Tripsas, Guang Yang et al. · Blood · 2013 · 52 citations

Medicine, Pharmacology, Pharmacotherapy +10